A
DGX icon

Astrantus’s Quest Diagnostics DGX Stock Holding History

Astrantus’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$383K Buy
+2,800
New +$390K 0.64% 62

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Davis Selected Advisers
Davis Selected Advisers Tucson, Arizona $23.3B AUM 26.95% 1-Year Est. Return
Grantham, Mayo, Van Otterloo & Co (GMO)
Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $44.4B AUM 36.05% 1-Year Est. Return

Astrantus's DGX Position: Q1 2022 in Review

Astrantus opened a new position in Quest Diagnostics (DGX) in Q1 2022: 2,800 shares worth $383K. The stake represents 0.64% of the portfolio and ranks #62 among its holdings.

851 funds tracked by Wall St. Rank hold DGX as of Q1 2022.

  • Astrantus held 2,800 shares of Quest Diagnostics worth $383K as of Q1 2022.
  • Quest Diagnostics was a new Astrantus position in Q1 2022.
  • Quest Diagnostics made up 0.64% of Astrantus's portfolio in Q1 2022, its #62 holding.
  • 851 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2022.

Based on Astrantus's 13F filing for Q1 2022, filed 11 May 2022.